M. Hernández

Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection

Hao Wu, Monica Cabrera-Mora, I. Sanz, 2020, bioRxiv.

Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load

X. Pechuan, Junkai Yang, A. Kosters, 2022, Blood Advances.

Inactivation of SARS Coronavirus 2 and COVID-19 patient samples for contemporary immunology and metabolomics studies

R. Schinazi, K. Zandi, Junkai Yang, 2021, bioRxiv.

Pathogenic neutrophilia drives acute respiratory distress syndrome in severe COVID-19 patients

X. Pechuan, Junkai Yang, A. Kosters, 2021, bioRxiv.

Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort study

P. Finn, D. Perkins, M. Ghassemi, 2023, medRxiv.

One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses

Henry M. Wu, H. Chu, I. Sanz, 2021, ImmunoHorizons.